Tempus AI
Tracked across 5 events · 47 articles · First seen Jun 24, 2026 · Last active Aug 22, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Tempus AI expands its precision oncology platform and MRD capabilities, expected to drive future growth and market share.
Jul 20, 2026 · 18 articles
Business
In late July and August 2026, top executives of Tempus AI, a healthcare technology company, sold significant amounts of company stock. CEO Eric Lefkofsky sold 250,000 shares on July 28, 2026, at an average price…
Impact: Tempus AI is the central company in this event. It reported strong Q2 earnings and announced a major acquisition, but insider sales and a declining stock price temper positive sentiment.
Jul 30, 2026 · 7 articles
Tech
Black Book Research, in partnership with Applied Artificial Intelligence LLC, published the 2026-2027 Life Sciences AI Technology Performance Benchmark on August 10, 2026. The independent study, based on feedback from 1,277 verified buyers and users,…
Impact: Named leader in discovery and clinical development AI, potentially boosting its market credibility.
Aug 10, 2026 · 6 articles
Business
Impact: Tempus AI is mentioned as a prior partner, indicating an existing relationship with Median Technologies, but is not directly involved in this agreement.
Jul 30, 2026 · 8 articles
Business
Impact: Acquired Paige AI for $81.25 million to expand AI pathology capabilities.
Jun 24, 2026 · 8 articles
90
Tempus AI agreed to acquire Chief Justice of HungaryTempus AI insider stock sales
80
Tempus AI reported earningsTempus AI insider stock sales
ERGEN INTELLIGENCE
Track Tempus AI live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard